维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="Mccloskey EV"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Alendronate in the treatment of Paget's disease of bone显示文摘	Khan SA Vasikaran S McCloskey EV	1997	Bone1997，20，3：	1
2	European guidance for the diagnosis and management of osteoporosis in postmenopausal women显示文摘	Kanis JA McCloskey EV Johansson H	2013	Osteoporosis Int2013，24，：	1
3	Case finding for the management of ostoporosis with FRAX-assessment and inter- vention thresholds for the UK 显示文摘	Kanis JA McCloskey EV Johansson H	2008	Osteoporos Int2008，19，10：	1
4	A reference standard for the description of osteoporosis显示文摘	Kanis JA McCloskey EV Johansson H	2008	Bone2008，42，3：	1
5	A reference standard for the description of osteoporosis显示文摘	Kanis JA McCloskey EV Johansson H	2008	Bone2008，42，3：	1
6	Rapid and robust response of biochemical markers of bone formation to teriparatide therapy 显示文摘	Glover SJ Eastell R McCloskey EV	2009	Bone2009，45，6：	1
7	Comparative effects of intravenous bisphosphonates on calcium and skeletal metabolism in man显示文摘	Mccloskey EV	1987	Bone1987，，：	1
8	European guidance for the diagnosis and management of osteoporosis in postmenopausal women 显示文摘	Kanis JA McCloskey EV Johansson H	2009	Osteoporos Int2009，24，：	1
9	Eunrpean guidance for the diagnosis anti management of trsteoporosis in postmenopausa!, women 显示文摘	Kanis JA McCloskey EV Johansson H	2013	Osteoporosis lnt2013，24，1：	1
10	Bisphosphonates in multiple myeloma显示文摘	Kanis JA McCloskey EV	2000	Cancer2000，88，12：	1
11	Long-term follow-up of a prospective,double-blind,placebo-controlled randomized trial of clodronate in multiple myeloma显示文摘	McCloskey EV Dunn JA Kanis JA	2001	Br J Haematol2001，113，4：	1
12	A reference standard for the description of osteoporosis 显示文摘	Kanis JA Mccloskey EV Johansson H	2008	Bone2008，42，3：	1
13	Eu- ropean guidance for the diagnosis and management of osteoporosis in postmenopausal women 显示文摘	Kanis JA McCloskey EV Johansson H	2013	Osteopo- ros Int2013，24，：	1
14	Ten-year fracture probability identifies women who will benefit from clodronate therapy- additional results from a double blind placebo-controlled randomised study 显示文摘	McCloskey EV Johansson H Oden A	2009	Osteoporos Int2009，20，5：	1
15	Rapid and ro- bust response of biochemical markers of bone formation to teriparatide therapy 显示文摘	Glover SJ Eastell R Mccloskey EV	2009	Bone2009，45，6：	1
16	European guidance for the diagnosis and management of osteoporosis in postmeno- pausal women显示文摘	Kanis JA McCloskey EV Johansson H	2013	Osteoporos Int2013，24，1：	1
17	European guidance for the diagnosis and management of osteoporosis in postmenopausal women 显示文摘	Kanis JA McCloskey EV Johansson H	2013	Osteoporos Int2013，24，1：	1
18	The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease显示文摘	Brown JE Mccloskey EV Dewar JA	2007	Calcif Tissue Int2007，81，5：	1
19	A systematic review of hip fracture incidence and probability of fracture worldwide 显示文摘	Kanis JA Oden A McCloskey EV	2012	Osteopo- ros Int2012，23，9：	1
20	Case finding for the man-agement of osteoporosis with FRAX? -Assessment and interventionthresholds for the UK显示文摘	Kanis JA McCloskey EV Johansson \{	2008	Osteoporos Int2008，19，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示